AXL and breast carcinoma: The relationship between AXL and resistance to immunotherapy was further investigated by Aguilera and colleagues, who found that in Py8119 cells, a mouse breast cancer cell line expressing Axl, radiotherapy combined with immune checkpoint inhibitors induced a limited initial immune response, exhibiting an immunotherapy-resistant state.